Correlation Engine 2.0
Clear Search sequence regions


  • AIM2 (1)
  • and disease (2)
  • cardiovascular diseases (4)
  • cytokines (3)
  • family (2)
  • focuses (1)
  • heart failure (1)
  • humans (1)
  • IL 18 (1)
  • IL 1β (2)
  • inflammasomes (9)
  • NLR (2)
  • NLRC4 (1)
  • NLRP1 (1)
  • NLRP3 (3)
  • Pyrin (2)
  • research (1)
  • risk factors (1)
  • Sizes of these terms reflect their relevance to your search.

    Cardiovascular diseases are known as the leading cause of morbidity and mortality worldwide. As an innate immune signaling complex, inflammasomes can be activated by various cardiovascular risk factors and regulate the activation of caspase-1 and the production and secretion of proinflammatory cytokines such as IL-1β and IL-18. Accumulating evidence supports that inflammasomes play a pivotal role in the progression of atherosclerosis, myocardial infarction, and heart failure. The best-known inflammasomes are NLRP1, NLRP3, NLRC4, and AIM2 inflammasomes, among which NLRP3 inflammasome is the most widely studied in the immune response and disease development. This review focuses on the activation and regulation mechanism of inflammasomes, the role of inflammasomes in cardiovascular diseases, and the research progress of targeting NLRP3 inflammasome and IL-1β for related disease intervention. Copyright © 2022 Liao, Liu and Zhu.

    Citation

    Yingnan Liao, Kui Liu, Liyuan Zhu. Emerging Roles of Inflammasomes in Cardiovascular Diseases. Frontiers in immunology. 2022;13:834289

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35464402

    View Full Text